Silo Pharma Announces Expansion of Intellectual Property Portfolio
February 2, 2023
MannKind Corporation to Participate in the BTIG Virtual Biotechnology Conference 2021
August 3, 2021
Related Post
-
-
First Wave BioPharma Announces First Patient Screened for Phase 2 SPAN Adrulipase Trial in Cystic Fibrosis
February 2, 2023
-
IDEAYA Biosciences to Participate in the 2023 Guggenheim Oncology Conference
February 1, 2023
-
Adial Pharmaceuticals Enters Into Option Agreement for Sale of Purnovate Assets to Adenomed
February 1, 2023